Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Valeant Pharmaceuticals Intl Inc    VRX   CA91911K1021

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Valeant Pharmaceuticals Intl : Health Care Higher As Paulson Joins Valeant Board - Health Care Roundup

share with twitter share with LinkedIn share with facebook
share via e-mail
0
06/19/2017 | 10:31pm CET

Shares of health-care companies rose as one big investor endorsed one of the hardest hit companies during the recent retreat from the sector. Hedge-fund billionaire John Paulson joined the board of Valeant Pharmaceuticals International, a sign that the investor remains bullish on the drugmaker's prospects despite the rout in Valeant's shares over the last year. The specialty drugmaker came under pressure after allegations of accounting improprieties and lost the support of some big institutional holders, such as William Ackman's Pershing Square. Medical-test maker PerkinElmer said it would buy a German medical-diagnostics company Euroimmun Medical Laboratory Diagnostics for $1.3 billion, expanding its reach into autoimmune and allergy testing.

-Rob Curran, [email protected]

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on VALEANT PHARMACEUTICALS IN
12/16 VALEANT PHARMACEUTICALS INTL : And One Of Its Subsidiaries Announce Early Tender..
12/16 VALEANT PHARMACEUTICALS INTL : And One Of Its Subsidiaries Announce Early Tender..
12/14 TSX in broad retreat led by Cenovus, other energy stocks
12/11 VALEANT PHARMACEUTICALS INTL : to Participate At the BMO Capital Markets 2017 Pr..
12/07 TSX gains in broad rally led by financials, energy stocks
12/07 VALEANT PHARMACEUTICALS INTL : To Participate At The BMO Capital Markets 2017 Pr..
12/06 VALEANT PHARMACEUTICALS INTL : International (65IB) IB Drugs, Pharmaceuticals an..
12/06 VALEANT PHARMACEUTICALS INTL : 65-- Valeant Pharmaceuticals International (65IB)..
12/06 VALEANT PHARMACEUTICALS INTL : Announces Launch of Private Offering of Senior No..
12/05 VALEANT PHARMACEUTICALS INTL : Class-action suit against Valeant set to go to tr..
More news
Financials ($)
Sales 2017 8 731 M
EBIT 2017 3 316 M
Net income 2017 156 M
Debt 2017 25 448 M
Yield 2017 -
P/E ratio 2017 4,04
P/E ratio 2018
EV / Sales 2017 3,70x
EV / Sales 2018 3,61x
Capitalization 6 876 M
Chart VALEANT PHARMACEUTICALS IN
Duration : Period :
Valeant Pharmaceuticals In Technical Analysis Chart | VRX | CA91911K1021 | 4-Traders
Technical analysis trends VALEANT PHARMACEUTICALS IN
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
 
Mean consensus HOLD
Number of Analysts 18
Average target price 16,0 $
Spread / Average Target -19%
EPS Revisions
Managers
NameTitle
Joseph C. Papa Chairman & Chief Executive Officer
Paul S. Herendeen Chief Financial Officer & Executive VP-Finance
Tage Ramakrishna Chief Medical Officer, President-R&D
Robert N. Power Independent Director
David Robert Hale Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
VALEANT PHARMACEUTICALS INTL INC35.54%6 876
JOHNSON & JOHNSON22.95%382 722
PFIZER12.25%221 738
NOVARTIS13.09%221 731
ROCHE HOLDING LTD.3.91%212 270
MERCK AND COMPANY-4.86%153 386